Skip to main content

Tekmira Closes $5.2M Offering

Premium

Tekmira Pharmaceuticals said this week that it has closed a previously announced public offering of more than 1.7 million units of stock and warrants, grossing the company C$5.1 million ($5.2 million).

Each unit consists of one share of common stock and a half a warrant to purchase one common share, the company said.

Proceeds of the offering will be used for general corporate purposes, Tekmira said.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.